US Stock MarketDetailed Quotes

AMPE Ampio Pharmaceuticals

Watchlist
  • 0.002
  • 0.0000.00%
15min DelayClose Feb 14 16:00 ET
2.38KMarket Cap0.00P/E (TTM)

About Ampio Pharmaceuticals Company

Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in December 2008 and is headquartered in Englewood, CO.

Company Profile

SymbolAMPE
Company NameAmpio Pharmaceuticals
Listing DateNov 22, 2022
Founded2008
CEOMr. Michael A. Martino
MarketPink Market
Employees6
Fiscal Year Ends12-31
Address9800 Mount Pyramid Court,Suite 400
CityEnglewood
ProvinceColorado
CountryUnited States of America
Zip Code80112
Phone1-720-437-6500

Company Executives

  • Name
  • Position
  • Salary
  • Michael A. Martino
  • Director and Chief Executive Officer
  • --
  • Daniel G. Stokely
  • Chief Financial Officer, Chief Accounting Officer and Secretary
  • --
  • J. Kevin Buchi
  • Chairman of the Board
  • --
  • Dr. David R. Stevens,PhD
  • Independent Director
  • --
  • Elizabeth Varki Jobes, Esq.
  • Independent Director
  • --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.